Last updated 2026-07-20
- Raised Undisclosed Round led by RAD BioMed, Dec 2005
- Raised grant, Dec 2005
Total raised
—
Last: Undisclosed Round 2006-01
Stage
Mature
Founded
2016
Headcount
1-10
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Situgen Med is an Israeli company focused on developing novel devices for the effective, reproducible, and cost-effective extraction of Umbilical Cord Blood (UCB) for stem cell collection. Their primary product is a disposable device and kit designed to maximize the volume of collected cord blood and the number of stem cells harvested, addressing the limitation of current collection methods. The company is active in research and development in the fields of Stem Cells, Cord Blood, and Placenta-Umbilicus Coagulation.
Funding history · 2 rounds · — total
2005-12
Undisclosed Round
Undisclosed
★ RAD BioMed
2005-12
Grant
Undisclosed
Headcount over time
From 1 (2019-11) to 6 (2022-04) · +5 (+500%) · 2 points · source: Finder history + radar grounding
Q&A
- What is Situgen Med's primary business?
- Situgen Med is a medical device startup focused on developing a comprehensive system for extracting stem-cell-rich umbilical cord blood.
- What is the name of Situgen Med's patented product?
- Situgen Med's patented product is the SG1040, a disposable, all-inclusive, non-contaminating collection kit designed to improve the quality of cord blood and increase the number of stem cells extracted.
- What is a key feature of the SG1040 device?
- The SG1040 device is needle-free, which helps prevent the bottleneck effect typically associated with traditional needle-based collection methods.
- When was Situgen Med founded?
- Situgen Med was founded in January 2006.
- Where is Situgen Med headquartered?
- Situgen Med is headquartered in Tel Aviv-Yafo, Israel.
- What is Situgen Med's employee count?
- Situgen Med has 1-10 employees.
- Which group is Situgen Med a part of?
- Situgen Med is part of the Rad-Bynet Group of multinational technology companies.
- Which investor participated in Situgen Med's funding round in January 2006?
- RAD BioMed participated in Situgen Med's funding round in January 2006.
Team · 2
Prof. Arnon Nagler
Founder · Co-Founder
Dr. Miki Shacham
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical Products
Business model
B2B
Highlights
1 Patents
Tags
medical-devicespregnancymedical-technologiesminimally-invasiveblood-testnon-invasivehematology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | situgen.com |
|---|---|
| linkedin.com/company/17882433 |
Identifiers & details
| Legal name | SITUGEN MED LTD |
|---|---|
| Founded | 2016-1 |
Radar intelligence
Web history (Wayback)
| Domain | situgen.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|